SSSuse D. Silva-Barbosa

Suse D. Silva-Barbosa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Suse D. Silva-Barbosa has a total of 16 co-authors. Here are the top co-authors by number of shared publications:

  • Ana Cma Nogueira

    Department of Immunology, National Institute of Quality Control and Health, INCQS, FIOCRUZ – Rio de Janeiro, Rio de Janeiro, Brazil

    1 shared publication
  • André Almeida Schenka

    Department of Pharmacology, School of Medical Sciences, State University of Campinas (Unicamp), São Paulo, Brazil Laboratory of Investigative Pathology, Department of Anatomic Pathology, Hospital AC Camargo, São Paulo, Brazil Laboratory of Investigative and Molecular Pathology, Center for Investigation in Pediatrics (Ciped), São Paulo, Brazil

    1 shared publication
  • Camila Maria Longo Machado

    Center for Translational Research in Oncology (LIM/24), Instituto do Câncer do Estado de São Paulo, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo CEP 01246-000, Brazil

    1 shared publication
  • Fátima Boetcher-Luiz

    Department of Obstetrics and Gynecology, Faculty of Medical Sciences, UNICAMP – Campinas, São Paulo, Brazil

    1 shared publication
  • Gillian Butler-Browne

    Center for Research in Myology U974, Sorbonne Université, INSERM, Myology Institute, Paris, France

    1 shared publication
  • Ingo Riederer

    1 shared publication

Latest Publications

  • Open Access

    Characterization of cells recovered from the xenotransplanted NG97 human-derived glioma cell line subcultured in a long-term in vitro

    by Camila Ml Machado, Rafael Y Ikemori, Tatiana Q Zorzeto, Ana Cma Nogueira, Suse Ds Barbosa, Wilson Savino, André A Schenka, José Vassallo, Juliana K Heinrich, Fátima Boetcher-Luiz, et al.

    In order to elucidate tumoral progression and drug resistance, cultured cell lines are valuable tools applied on tumor related assays provided they are well established and characterized. Our laboratory settled the NG97 cell line derived from a human astrocytoma grade III, which started to develop and express important phenotypical characteristics of an astrocytoma grade IV after injection in the flank of nude mice. Astrocytomas are extremely aggressive malignancies of the Central Nervous System (CNS) and account for 46% of all primary malignant brain tumors. Progression to worse prognosis occurs in 85% of the cases possibly due to changes in cell tumor microenvironment and through biological pathways that are still unclear.


  • Human Myoblast Engraftment Is Improved in Laminin-Enriched Microenvironment

    by Suse D. Silva-Barbosa, Gillian S. Butler-Browne, Wallace de Mello, Ingo Riederer, James P. Di Santo, Wilson Savino, Vincent Mouly

    One major challenge in developing cell therapy for muscle diseases is to define the best condition for the recipient's muscle to niche donor cells. We have examined the efficiency of human myoblast transplantation in an immunodeficient animal model, after local irradiation, as well as the potential impact of laminin on myoblast behavior. Human myoblasts were injected into preirradiated tibialis anterior muscles from immunodeficient mice. The donor cell engraftment, proliferation, and laminin content within the transplanted muscles were evaluated by immunocytochemistry. Additionally, the effect of laminin upon myoblast proliferation, migration, and survival was ascertained in vitro. Engraftment of human myoblasts into the skeletal muscle of immunodeficient Rag2-/gammac-/C5- mice presubjected to local irradiation provided the best niche for myoblast engraftment, as demonstrated by the number of viable and proliferating donor cells found in the host muscle. Local irradiation significantly enhanced laminin deposition within the recipient's muscle and donor cells were preferentially located in laminin-enriched areas. The same batch of myoblasts used for in vivo injections also responded to laminin in vitro with increased proliferation and cell survival, as well as an improved migratory response. We show that local irradiation enhances the laminin content in the host muscle microenvironment and provides a better engraftment of human myoblasts. In addition, laminin increases myoblast proliferation, survival, and migration in vitro. These data provide combined in vivo and in vitro evidence that laminin status should be taken into account when designing experimental and clinical cell therapy strategies for muscle disease.